Molecular Subtypes of Neuroendocrine Carcinoma: From Chaos to Consensus

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Neuroendocrine carcinomas (NECs) are aggressive malignancies with diverse origins.
• Molecular subtyping using transcription factors like ASCL1, NEUROD1, POU2F3, and YAP1 has improved understanding of small cell lung cancer (SCLC) heterogeneity.
• Extrapulmonary NECs exhibit similar heterogeneity driven by these factors, with a fifth subtype identified (HNF4A).

Purpose of the Study:

• To propose a unified pan-NEC classification framework for consistent molecular subtyping.
• To integrate understanding of NEC heterogeneity across pulmonary, gastro-entero-pancreatic (GEP), and genitourinary systems.
• To connect molecular subtypes to biological mechanisms, genetic alterations, and clinical features.

Main Methods:

• Literature review and synthesis of existing research on NEC molecular subtyping.
• Delineation of lineage hallmarks for the proposed ANHPY subtypes.
• Exploration of connections between subtypes, mechanisms, genetics, and therapeutics.

Main Results:

• Identification of five core subtypes (ANHPY): neuroendocrine, neuronal, GEP-like, tuft-like, and epithelial-mesenchymal transition phenotypes.
• Demonstration of conserved transcriptional determinants governing NEC heterogeneity across anatomical sites.
• Establishment of links between molecular subtypes and distinct clinicopathological features and therapeutic vulnerabilities.

Conclusions:

• A unified pan-NEC classification framework (ANHPY subtypes) provides a consistent molecular roadmap.
• This framework facilitates precise research and management of NECs.
• Understanding these subtypes is crucial for advancing NEC diagnosis and treatment strategies.